ArticleThe Journal of clinical investigation2025

Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomas.

Yaniv Kazansky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.